CTRI/2010/091/000569已完成3 期
A multicentric, open label, noncomparetive clinical trial to assess efficacy and safety of a fixed dose combination of meropenam and sulbactam in lower respiratory tract infection caused by Gm (-ve) organisms including Pseudomonas aeruginosa.
MsVHB Medisciences Ltd0 个研究点目标入组 200 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Male and female subjects in the age group of 18-60 years have been selected.
- •2. Clinically diagnosed subjects lower respiratory infection with Gram (-)ve.
- •3. Subjects willing to give informed consent.
- •4. Patient must not have received any antibiotics in previous 4 week.
排除标准
- •1. History of hypersensitivity reaction or any specific contraindication to ofloxacin or ornidazole or Quinolone group or nitoimidazole group.
- •2. Presence of hepatic or renal disorders,
- •3. Pregnancy or lactation,
- •4. History of hearing loss,
- •5. Alcoholics
- •6. Previous history seizure or taking anti epileptic drugs.
研究者
相似试验
已完成
3 期
A Clinical Trial to Evaluate Safety and Tolerability of Lacosamide Injection for the treatment of epilepsyCTRI/2011/07/001888Torrent Pharmaceuticals Ltd60
招募中
4 期
Safety and Tolerability study of Lacosamide Injection in Patients withPartial Onset Seizures.CTRI/2014/12/005260Torrent Pharmaceuticals Ltd200
招募中
4 期
A Post Marketing Survillance study ( EASE ) to study the efficacy & safety of Xolair ( Omalizumab) in IgE mediated Asthma.CTRI/2010/091/000067ovartis Healthcare Private Limited50
已完成
4 期
gastroesophageal reflux disease (GERD) studyCTRI/2015/08/006140Torrent Pharmaceuticals Ltd500
尚未招募
4 期
Multicenter, openlabel, noncomparative, clinical decision basedpostmarketing surveillance (PMS) study forEvaluation of efficAcy and Safety of Xolair (Omalizumab)in IgE mediated Asthma in Pediatric patientsCTRI/2013/03/003478ovartis Healthcare Private limited50